Demo mode. In production, this would be authentication-driven. Each role sees only what's relevant to their workflow.
VL
Vivre Labs
Institutional Longevity
- Peptides -
- Single-vial Blends -
- Goals -
- Clinical Reference -
- Guides -
- Integrity -
◇ Goal · Look Better - Skin & Weight
Aesthetic, body composition, and dermal architecture - addressed clinically, not cosmetically.
Vivre's aesthetic protocols address the underlying physiology - adipose tissue distribution, dermal collagen and copper-binding kinetics, regenerative signalling. The compounds are administered under physician supervision with biomarker monitoring. This is medicine, not a med-spa appointment.
The Vivre Approach
Physician-supervised. Biomarker-anchored. Not protocol-on-demand.
Biological audit first
Every protocol starts with a comprehensive biological baseline - body composition, metabolic panel, inflammatory markers, hormone panel. We don't prescribe without data.
Physician judgment
A Vivre-network physician reviews your audit and discusses what protocol - if any - is appropriate. Some patients are better served by lifestyle interventions alone.
Continuous monitoring
Protocols include scheduled biomarker re-testing. We track your trajectory, not just outcomes. If something isn't responding, the physician adjusts.
Relevant ProtocolsPhysician-supervised stacks
The protocols below address aesthetic and body-composition goals through distinct physiological mechanisms. Your audit determines which fits your case - frequently the answer is a combination, sequenced clinically.
The Peptides in These Protocols
Individual compounds
Patients often search by compound name (Tirzepatide, BPC-157, GHK-Cu) - not by protocol code. Here are the individual compounds that appear in Vivre's aesthetic protocols, grouped by what they do. Click any compound for its detailed clinical page, including evidence base, half-life, and mechanism.
GLP-1 metabolic medications
· appetite regulation, glucose handling, body weight
Note: which compounds a given patient receives is determined at consultation, not by self-selection. Vivre's V-Series protocols package these compounds clinically; individual compound pages exist for education and physician reference.
How It Works
01
Biological Audit
Comprehensive baseline - body composition, metabolic panel, inflammatory markers, hormone work. The audit takes approximately 60 minutes and provides the data foundation for everything that follows.
02
Physician Consultation
A Vivre-network physician reviews your audit and discusses what protocol - if any - is appropriate for your case. Honest scenarios include "not the right time for a peptide protocol" if biomarkers indicate other interventions first.
03
Supervised Protocol
Protocol begins with the verified compound supply and the diagnostic scaffolding. Scheduled re-testing tracks biomarker trajectory. Adjustments are clinical, not promotional.
What Makes This Different
The medical-spa peptide market is large and varies enormously in quality. The distinguishing features of a clinically-credible programme:
Compound verification. Vivre's Double-Gate Protocol verifies every compound batch (HPLC purity + third-party mass spectrometry). Most medical-spa peptide programs do not.
Physician judgment, not protocol-on-demand. Protocols are declined when biomarkers indicate they're not appropriate. Most direct-to-consumer programs sell to whoever asks.
Biomarker monitoring as standard. Vivre includes scheduled re-testing across protocol duration. Most programs monitor only at intake.
Evidence honesty. Vivre's compound pages document evidence quality openly - including when evidence is thin (e.g. Russian-origin neuropeptides, single-research-group bioregulators). Most retailer-grade content overstates evidence uniformly.
Evidence Base · Aesthetic Compounds
Primary sources · peer-reviewed
The compounds in Vivre's aesthetic protocols are supported by distinct evidence tiers - from Phase 3 RCTs to established human biochemistry to well-characterised preclinical mechanism. Vivre presents each at the level of evidence that actually exists.
Tier indicators (gold = human RCT, biochemistry, or genomic; amber = preclinical or investigational) reflect translational distance. Vivre presents human data prominently and flags preclinical evidence explicitly so patients and physicians can weigh it honestly. Click any card for full study breakdown on the compound page.
Common Questions
Is this safe for me?
That is what the biological audit and the physician consultation answer. Some patients are better candidates for these protocols than others - the audit identifies contraindications. Honest answer: if biomarkers indicate underlying issues that need addressing first, the physician will say so.
Will I regain the weight after the protocol?
For GLP-1-class compounds in particular, this is the central clinical question. The Vivre approach uses tissue-protective adjuncts (e.g. growth-hormone-axis support via Tesamorelin) alongside the metabolic intervention specifically to preserve lean mass during loss - which is the strongest predictor of sustained outcomes. Maintenance protocols and lifestyle support are part of the design.
What about menopause or perimenopause considerations?
Hormonal context affects how every protocol behaves. The audit includes the hormone work, and the physician consultation explicitly discusses life-stage considerations. If hormone replacement is part of the appropriate plan, Vivre works through the physician network on this - Vivre does not prescribe HRT directly.
How is this different from Ozempic or Wegovy alone?
GLP-1 monotherapy produces meaningful weight loss but is associated with substantial lean-mass loss. Vivre's approach addresses this by pairing the metabolic intervention with tissue-protective and regenerative compounds, with biomarker monitoring throughout. The protocol is also clinical-grade - physician-supervised, verified compounds - rather than a telehealth prescription with minimal monitoring.
How long does the consultation take?
Initial audit appointment is approximately 60 minutes. Your practice sets its own consultation format. Protocol begins after these two appointments and a brief biomarker-result review period.
Next Step
Start with the Biological Audit.
The audit provides the foundation. From there, the physician consultation determines whether and how a protocol fits your case.